Awareness, perceptions, and choices of physicians pertaining to human papillomavirus (HPV) vaccination in India: A formative research study.
Awareness
Cervical cancer
HPV vaccination
Human papillomavirus virus
India
Perception
Physician
Journal
Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
27
01
2022
revised:
26
08
2022
accepted:
13
10
2022
entrez:
1
11
2022
pubmed:
2
11
2022
medline:
2
11
2022
Statut:
epublish
Résumé
India accounts for one-fifth of the global burden of cervical cancer cases and mortality. A safe and effective vaccine to prevent human papillomavirus (HPV) infections, the primary cause of cervical malignancies, is available in India but multiple barriers lead to its low uptake in the country. Physicians are a key stakeholder and communicator in the Indian health system and have the potential to increase HPV vaccine uptake. We undertook formative research to understand awareness, perceptions and choices of physicians when recommending the HPV vaccine to parents of adolescent girls. We conducted in-depth interviews with 32 physicians in two districts of West Bengal. Data collection was carried out between July and August 2019. The data was transcribed, coded, and analyzed using NVivo software using the thematic analysis technique. Our findings suggest that while physicians are generally aware about the burden of cervical cancer and its prevention by HPV vaccination, they face several barriers to recommending the HPV vaccine routinely and strongly. These include the lack of national-level guidance on the age eligibility and dosage, lack of practice-level opportunities such as well or non-sick visits and other routine adolescent vaccines, practice-level barriers like out-of-pocket cost and vaccine availability, and perceived parental hesitancy arising from reluctance to discuss cervical cancer, its prevention, and HPV vaccination. Physicians in our study exhibited hesitancy when recommending the HPV vaccine. They also faced logistical barriers. It is important that the barriers pertaining to when and how physicians recommend the vaccine be tackled through further education, policy change, and development and implementation of interventions that are evidenced-based.
Identifiants
pubmed: 36317080
doi: 10.1016/j.jvacx.2022.100228
pii: S2590-1362(22)00088-2
pmc: PMC9617192
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100228Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Am J Health Promot. 1996 Mar-Apr;10(4):247-51
pubmed: 10159704
Vaccine. 2011 Jan 29;29(5):890-5
pubmed: 20056186
Asian Pac J Cancer Prev. 2015;16(18):8473-7
pubmed: 26745104
Lancet Oncol. 2019 Nov;20(11):e637-e644
pubmed: 31674322
PLoS One. 2012;7(7):e40619
pubmed: 22859950
South Asian J Cancer. 2013 Oct;2(4):193-7
pubmed: 24455622
Vaccine. 2011 Nov 3;29(47):8634-41
pubmed: 21924315
Am Psychol. 1992 Jan;47(1):6-22
pubmed: 1539925
J Cancer Educ. 2017 Jun;32(2):382-391
pubmed: 26880357
Int J Dermatol. 2014 Nov;53(11):e486-91
pubmed: 24961359
Indian J Med Ethics. 2010 Jan-Mar;7(1):38-41
pubmed: 20166299
J Adolesc Health. 2010 Apr;46(4):379-84
pubmed: 20307828
Pediatrics. 2017 Jan;139(1):
pubmed: 27940512
JAMA Pediatr. 2014 Jan;168(1):76-82
pubmed: 24276343
J R Soc Med. 2012 Jun;105(6):250-62
pubmed: 22722970
Vaccine X. 2019 Aug 05;3:100037
pubmed: 31463471
Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1673-9
pubmed: 26494764
Pediatrics. 2018 Jun;141(6):
pubmed: 29765009
Health Educ Q. 1988 Winter;15(4):351-77
pubmed: 3068205
N Engl J Med. 2015 Feb 19;372(8):711-23
pubmed: 25693011
Vaccine. 2008 May 23;26(22):2669-79
pubmed: 18455843
Prev Med. 2021 Feb;143:106323
pubmed: 33171178
Int Health. 2013 Sep;5(3):205-10
pubmed: 24030271